Alzheimer's Disease:: A Potential $1.1 Trillion Call For Innovative Financial Products and Meaningful Tax Reform

Alzheimer’s disease (AD) is the third leading cause of nonaccidental death in America. Today, 5 million Americans struggle with AD at a cost of $215 billion. It is estimated that by 2050, the number of people with AD will increase to 13.5 million at a cost of $1.1 trillion. Medicare and Medicaid are not in a position to finance this looming disaster. This book introduces two innovative financial products designed to help fund this medical crisis. It offers ideas about tax reform to help assist caregivers in meeting personal financial costs that up to now are leaving many families financially insolvent.